JP Morgan Chase’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,700
Closed -$271K 7532
2023
Q3
$271K Buy
+19,700
New +$355K ﹤0.01% 4863

Other funds holding BMEA

JP Morgan Chase's BMEA Position: Q2 2026 in Review

JP Morgan Chase increased its Biomea Fusion (BMEA) stake by 2,624% in Q2 2026, buying an estimated $4.23K and bringing the position to 2,942 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #7105.

JP Morgan Chase first reported a position in BMEA in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.11M in Q1 2023. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • JP Morgan Chase held 2,942 shares of Biomea Fusion worth $4.09K as of Q2 2026.
  • JP Morgan Chase bought 2,834 Biomea Fusion shares in Q2 2026, an estimated $4.23K.
  • Biomea Fusion made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7105 holding.
  • JP Morgan Chase first reported a position in Biomea Fusion in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Biomea Fusion position peaked at $5.11M in Q1 2023.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.